Aptar’s History of Innovation

Aptar’s history of innovation has helped make it a global leader in drug and consumer product dosing, dispensing and protection technologies.

About Aptar

Adapting to Make Your Life Better

Aptar is built on a lifetime of adapting solutions and changing the future. Our products and solutions transform end-markets, revolutionize categories and enhance the lives of millions of people around the globe through

We may be known for our molding technologies, but it’s our ability to mold and maintain long-term relationships with the world’s leading brands that makes us special.

This legacy underlies a distinctive corporate culture strengthened by strong leadership, unique team-members and dedicated share-holders that all believe in Aptar’s purpose: Transforming ideas into solutions that improve everyday life. 

What started out as three entrepreneurs from the U.S., Germany and France has evolved into a company that spans the globe.

This same entrepreneurial spirit can be found everyday through our commitment to sustainability and innovation. Watch our video below to learn more.

A Look Back

Take a look into the Aptar legacy, from the early days of our founding companies, to the year we became an independent company trading on the New York Stock Exchange, to the innovative packaging and drug delivery solutions leader that we are today.

1940 - 1960

  • Our founding companies started in the US, France and Germany

1960 - 1980

  • Acquired by the Pittway Corporation
  • Started manufacturing spray valves and pumps

1980 - 2000

  • Started molding dispensing closures
  • Aptar becomes a publicly traded company in the New York Stock Exchange, 1993

2000 - Today

  • $3.5 billion in revenue with over 13,000 employees in 20 different countries
  • One of Barron’s Top 100 Most Sustainable Companies in America
  • One of Newsweek’s Most Responsible Companies
  • Among the ‘World’s Top Companies for Women’ by Forbes
  • One of TIME’s World’s Most Sustainable Companies
  • 3BL Media’s 100 Best Corporate Citizens

Latest from Aptar

23 Sep 2024

Aptar’s N-Sorb Nitrosamine Mitigation Solution Accepted to US FDA’s Emerging Tech...

Press Releases, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Customer Success Story

Read More
20 Sep 2024

Working At Aptar: Fostering Kindness

Article, Working at Aptar, Brand Differentiation

Read More
9 Sep 2024

Aptar Pharma Announces Agreement with Pulmotree to Develop and Promote Kolibriâ„¢ Non...

Press Releases, Pharmaceutical, Innovation & Insights, Device Innovations, Brand Differentiation, Product Solutions

Read More
5 Sep 2024

Aptar Digital Health Announces New Asthma Clinical Study with Guy’s and St Thomasâ€...

Press Releases, Pharmaceutical, Brand Differentiation, Product Solutions, Innovation & Insights, Device Innovations

Read More
1 3 4 5 6 7 166